Our History & Mission
AIBMR is a scientific and regulatory consulting firm founded in 1978. We are one of the oldest natural products consulting firms in North America, focusing on Independent GRAS conclusions (Self-Affirmed GRAS or GRAS Self-Determinations), FDA GRAS conclusions, FDA NDI notifications, toxicology studies, scientific publications and general FDA and FTC regulatory compliance, such as label reviews and claims substantiations for the food and dietary supplement industries. We maintain an extensive scientific and natural products library, including a rare botanical medicine collection.
Our team is especially unique, as it is comprised of naturopathic physicians and a PhD scientist. Naturopathic physicians are licensed as primary care physicians in a number of U.S. states, and are trained in medicinal diagnostics and pharmaceutical treatments along with natural medicine modalities, including nutrition, botanical medicine, pharmacognosy, behavioral sciences, homeopathy, preventative medicine, lifestyle counseling, and dietary supplements. In addition, our staff has training and experience in toxicology, basic science and clinical research, biostatistics & epidemiology, dietetics, library sciences and decades of experience in FDA and FTC regulatory consulting and toxicological sciences, collectively providing a unique perspective for our clients in the food and supplement industries.
Alexander Schauss, PhD, FACN, CFS
AIBMR’s founder, Dr. Schauss, is a leader in nutraceutical research and consulting. He is uncompromising in pursuing the highest quality research standards for AIBMR Life Science’s clients while helping them profit. Dr. Schauss has built an extensive world-wide professional network and gathered an immeasurable pool of knowledge and experience. His expertise extends to introducing AIBMR Life Science’s clients to this network, offering secure, responsible and trustworthy working relationships with competent partners.Read More
Alexander Schauss, PhD, FACN, CFS, is the Senior Research Director of Natural and Medicinal Products Research, and CEO at AIBMR Life Sciences, with staff in Arizona, California, Colorado, Massachusetts, Michigan, New York, Ohio, Oregon, and Washington. As lead scientist, Dr. Schauss has worked on projects in 55 countries for AIBMR to support research activities for over 500 companies or institutions. He earned his undergraduate, graduate (summa cum laude), and doctoral degrees at the University of New Mexico at Albuquerque and, California Coast University in Santa Ana, respectively, completing post-graduate studies or continuing education at the University of New Mexico, the University of Washington at Seattle, University of Washington at Tacoma, the University of Puget Sound, the University of Texas Medical Branch at Galveston, Stanford University, Georgia State University, University of Georgia, and California State University – Fullerton. Currently, he is a Research Associate in the Geosciences Department, College of Science, and the Bio5 Institute, Office of Research, Discovery & Innovation, at the University of Arizona
Dr. Schauss has studied nutrition and botanical medicine since 1969, when he performed his first clinical trial on the use of high dose oral vitamin C and its effects on opioid receptors in the treatment of heroin addiction; a landmark study that attracted the attention of two-time Nobel Laureate, Dr. Linus Pauling. Since then he has held a number of academic positions, including Clinical Professor of Natural Products Research and Adjunct Research Professor of Botanical Medicine at the National College of Natural Medicine in Portland, Oregon; Senior Director of the Southwest College Research Institute in Scottsdale, Arizona; Associate Professor of Research at the Southwest College of Naturopathic Medicine and Health Sciences in Tempe, Arizona; Director, Institute for Biosocial Research, City University, Seattle; and, Lecturer in Biostatistics and Epidemiology at Bastyr University in Seattle.
He has been a member of the National Institutes of Health (NIH) Office of Alternative Medicine (OAM) Advisory Council (AMPAC); a member of the Ad Hoc Developmental Planning Committee of the NIH Office of Dietary Supplements (ODS); a reviewer of botanical standards and information monographs for the U.S. Pharmacopoeia Convention (USP); and, a reviewer for the International Bibliographic Information on Dietary Supplements (IBIDS) database, maintained through an interagency partnership with the Food and Nutrition Information Center, National Agricultural Library, and U.S. Department of Agriculture (USDA). Currently, he serves on one of the expert panels of USP through 2015.
In 1985, Dr. Schauss was appointed to represent the United States as a voting member to the World Health Organization (WHO) Study Group on Health Promotion, based on the recommendation of the Director General of WHO, Dr. Hafdan Mahler, leading to his confirmation by the Secretary of the U.S. Department of Health and Human Services.
He is a member in good standing of the American Society of Nutrition, the Society for Experimental Biology in Medicine, the Society for Food Science and Technology, the American College of Toxicology, a Fellow of the American College of Nutrition (FACN), International Society of Regulatory Toxicology and Pharmacology, the American Chemical Society, and Society of Toxicology. He is also an Emeritus Member of the New York Academy of Sciences, former Chairman of the Food Policy Council of the National Council for Public Health Policy, an Honorary Founding Member of the British Society of Nutritional Medicine, and Emeritus Executive Director of the American Preventive Medical Association.
In 2005, Dr. Schauss received the Linus Pauling Lecture Award “for contributions to the medical sciences” from the American College for the Advancement of Medicine. In 1996 he was an official NGO member of the US FDA delegation to the Codex Meeting on Special Nutritionals held in Bonn, Germany. In 2006, Dr. Schauss is credited with originating Supplementology™, defined as technical consultation in the field of research, development and formulation of nutraceutical, botanical and natural preparations.
Besides serving on numerous Generally Recognized as Safe (GRAS) Independent Determination expert panels, for 23 years he served on the Compliance and Label Integrity Committee of the National Products Association, and helped develop the nation’s first Good Manufacturing Practices (GMP) guidelines for the dietary supplement industry, much of which is today incorporated into the FDA’s GMP regulations for this industry.
He is the author or co-author of over 260 publications that have appeared in a diverse range of scientific journals, including: Atherosclerosis, Experimental Gerontology, Toxicology, Journal of Agricultural and Food Chemistry, Food Chemistry, Regulatory Toxicology and Pharmacology, Renal Failure, Food and Chemical Toxicology,International Journal of Neurology, International Journal of Toxicology, Nutrition Research, Biological Trace Element Research, Journal of Nutritional Biochemistry, Journal of Medicinal Food, and, the Journal of the American College of Nutrition.
Besides being the author/co-author of 23 books in the fields of nutrition and botanical medicine, some of which have been published in numerous languages, Dr. Schauss has contributed 39 chapters to a wide range of edited works, including chapters in all editions of the Textbook of Natural Medicine (Elsevier Science: Oxford, UK); the review chapter on tocotrienols in the definitive work, Tocotrienols: Vitamin E Beyond Tocopherols (CRC Press: Boca Raton, FL), on the safety of Tocotrienols; The Safety of Tocotrienols, in Tocotrienols: Vitamin E Beyond Tocopherols, Second Edition (Taylor & Francis/CRC Press); Culinary Spices in Cancer Chemoprevention, in Bioactive Foods and Extracts – Cancer Treatment and Prevention (CRC Press, Taylor & Francis: Boca Raton, FL); three chapters in Bioactive Foods in Promoting Health (Academic Press: Oxford, UK); Botanical Foods in Cancer Treatment and Prevention (Academic Press: Oxford, UK); Dried Fruits – Phytochemicals and Health Applications (Blackwell/Wiley & Sons: Chichester, UK); Bioactive Foods as Dietary Interventions for Arthritis and Related Inflammatory Diseases (Elsevier: Oxford, UK), and Fruits, Vegetables, and Herbs: Bioactive Foods in Health Promotion (Academic Press, Oxford); and, Citicoline (CDP-Choline) in the Textbook of Natural Medicine, 5th Edition.
John R. Endres, ND
Chief Scientific Officer
Dr. Endres, ND has been AIBMR Life Science’s Chief Scientific Officer since 2006. He coordinates a team of scientific and regulatory consultants to the functional foods and dietary supplement industries. Dr. Endres helps AIBMR Life Science’s clients to meet their goals by working closely with them to develop practical research strategies. He is very involved with GRAS Self-determinations, FDA GRAS Notifications, FDA NDI Notifications, regulatory compliance, and toxicology studies at AIBMR. Dr. Endres offers professional and personalized service every step of the way with the highest degree of integrity and attention to detail.Read More
Dr. Endres is the chief scientific officer for AIBMR Life Sciences, Inc. in Seattle, Washington. Dr. Endres earned a degree in naturopathic medicine at Bastyr University in Kenmore, Washington in 2004 and is licensed by Washington State Department of Health as a physician. He is a full member of the Society of Toxicology (SOT). Dr. Endres has been a member of numerous expert panels assembled for the evaluation of GRAS Self-determinations. He meets frequently with FDA Office of Food Additive Safety (OFAS) in College Park, MD for FDA GRAS pre-notification meetings. Dr. Endres has been a contributing author on many safety assessments published in academic journals specializing in toxicology. He is frequently the monitoring scientist for toxicology studies designed to study the safety of ingredients to be added to foods and dietary supplements. Dr. Endres is on the Editorial Advisory Boards for Nutritional Outlook, Functional Ingredients, and is on the Executive Advisory Board for Vitafoods Europe. Most recently he became one of 33 voting members on the NSF International Joint Committee to develop Publically Available Standards (PAS) for GRAS on behalf of the Grocery Manufacturers Association (GMA). At AIBMR, he manages a team of scientific and regulatory consultants specializing in the natural products and functional foods industries.
Prior to his work at AIBMR, Dr. Endres was involved in cancer research conducted at the Bastyr University Research Institute (BURI) and Fred Hutchinson Cancer Research Center, both located in Seattle, Washington. He screened botanical extracts for their inhibitory effect on the growth of various cancer cell lines. A particular area of interest was garlic plant parts in various breast cancer cell lines as well as the anti–proliferative effects of Curcuma longa (turmeric) on various colon cancer cell lines. He has also been the recipient of grants to present research in the United Kingdom at Westminster University, Middlesex University, and Oxford Natural Products. He has also presented research at various venues, including American Medical Association sponsored conferences where, in 2001, he received an Award of Excellence in Research. Dr. Endres was a teaching assistant in laboratory chemistry and a research assistant in natural products research, with a focus on production, purification, and analytical chemistry of whole plant extracts while attending Bastyr University.
Amy Clewell, ND, DABT
Senior Vice President, Scientific and Regulatory Affairs
Dr. Amy Clewell is the Senior Vice President of Scientific and Regulatory Affairs at AIBMR Life Sciences. Dr. Clewell earned a Bachelor of Science degree in biology from Indiana University in Bloomington, Indiana and a doctoral degree in Naturopathic Medicine from Bastyr University in Kenmore, Washington. She maintains her physician’s license in the State of Washington. She has been a diplomat of the American Board of Toxicology since 2016, is a full member of the Society of Toxicology (SOT) and the American College of Toxicology (ACT), and has been a member of numerous expert panels assembled for the evaluation of GRAS independent conclusions.Read More
Dr. Clewell is an author on many peer–reviewed journal publications, especially related to the toxicological evaluation of food ingredients. Her authorship also includes book chapters and trade articles. She has over 16 years of experience in natural products regulatory consulting and specializes in the preparation of GRAS independent conclusion dossiers, as well as FDA GRAS notices and New Dietary Ingredient (NDI) notifications. She is also involved in the evaluation and compilation of scientific research on the efficacy of ingredients and regulatory compliance for natural products. She plays a strong role in the management of projects at AIBMR Life Sciences.
In addition to work at AIBMR, Dr. Clewell has clinical experience as a licensed physician in Washington State, as well as extensive research experience. Her work in research began as a student and laboratory technician as an undergraduate at Indiana University where she spent three years working in the area of translational initiation using Saccharomyces cerevisiae as a model system. She continued her research pursuits for another five years as a research technician and laboratory manager in Dr. Karla Kirkegaard’s laboratories at both the University of Colorado and Stanford University, studying the biochemistry of polio and hepatitis C virus propagation using an S. cerevisiae model. She remained active in research in various capacities while attending Bastyr University for her doctorate. She is the past president of the Indiana Association of Naturopathic Physicians and a current member of the American Association of Naturopathic Physicians.
Timothy Murbach, ND, DABT
Vice President, Scientific & Regulatory Affairs
Timothy Murbach, ND, DABT is Vice President of Scientific & Regulatory Affairs at AIBMR Life Sciences. Dr. Murbach received his doctor of naturopathic medicine, with high honors, from the National University of Natural Medicine in Portland, Oregon and currently maintains his naturopathic physician’s license in the State of Washington (previously having been licensed in Oregon and California). He earned a bachelor of science degree in biology, with a minor in chemistry, from Oregon State University, graduating summa cum laude. Dr. Murbach is a diplomate of the American Board of Toxicology and holds membership in the Society of Toxicology and the American College of Toxicology.Read More
At AIBMR Life Sciences, Dr. Murbach applies critical evaluation in reviewing and interpreting scientific studies in terms of safety and toxicological parameters, mechanisms of action, clinical applications, bioactivities, and efficacy. He has been a contributing author on multiple peer-reviewed journal articles related to the toxicological evaluation of food ingredients, has been a member of numerous expert panels assembled for the evaluation of GRAS independent conclusions, and his work is focused on the preparation of safety assessment dossiers for independent conclusions of GRAS status, FDA GRAS notices, and FDA new dietary ingredient notifications.
Prior to his work at AIBMR, Dr. Murbach practiced primary care naturopathic medicine at both the Integrative Medical Group of Irvine, in Irvine California, and Salem Natural Medicine, in Salem, Oregon following a one-year heart and lung rotation at the Center for Natural Medicine during his internship and a clinical residency in IV micronutrient therapy at Tigard Holistic Health Clinic. He has also been an adjunct faculty member at the Helfgott Research Institute in Portland, Oregon, and participated in Oregon Health & Science University’s Human Investigations Program (an NIH CTSA grant funded program), where he developed a Parkinson disease study grant proposal. Dr. Murbach also served on the American Association of Naturopathic Physicians Electronic Health Records Task Force.
Kayla Preece, ND, DABT
Senior Scientific and Regulatory Consultant
Kayla Preece, ND, DABT, is a Senior Scientific and Regulatory Consultant at AIBMR. Dr. Preece, a diplomate of the American Board of Toxicology and full member of the Society of Toxicology, earned her doctoral degree in Naturopathic Medicine with a Certificate in Naturopathic Obstetrics and Childbirth from the National University of Natural Medicine (NUNM) in Portland, Oregon. She currently maintains her license in the state of Oregon.Read More
Dr. Preece’s undergraduate degree was in agroecology and she was an organic farmer for 7 years before returning to school to become a naturopathic physician. Her time and experience growing various types of plants has given her a unique perspective of the supply chain involved in food and supplement production. During her time at NUNM, Dr. Preece was a medicinary assistant, a community nutrition educator, and participated in extracurricular supplement manufacturing classes to further her education in herbal and nutritional supplements.
Maureen Dunn, ND, DABT
Senior Scientific and Regulatory Consultant
Maureen Dunn, ND, is a Senior Scientific and Regulatory Consultant at AIBMR. Dr. Dunn earned her doctorate in Naturopathic Medicine in 2012 from Bastyr University in Kenmore, Washington, and is a diplomate of the American Board of Toxicology. She has provided acute and chronic Naturopathic health care in both Vermont and North Carolina.Read More
Further, she created a virtual integrative health company offering Naturopathic health programs to individuals and groups to the general public. These programs included education, coaching and recommendations on diet, lifestyle and nutraceuticals for people with chronic diseases. She earned a Bachelor of Art degree in Environmental Studies from Mount Holyoke College in South Hadley, Massachusetts. She also received a Master in Public Affairs specializing in environmental policy from the University of Washington Evans School in Seattle, Washington. While at the Evans School she co-published a paper, Investments in Global Warming Mitigation: The Case of “Activities Implemented Jointly”. Prior to attending Bastyr, she worked as a consultant to the government on local environmental projects.
Vickie Modica, ND, DABT
Senior Scientific and Regulatory Consultant
Dr. Vickie Modica is a Senior Scientific and Regulatory Consultant at AIBMR. She is a full member of the Society of Toxicology, diplomate of the American Board of Toxicology, has authored or contributed to multiple peer–reviewed toxicological safety assessment publications, and has consulted on and written many independent conclusions of GRAS, FDA GRAS notifications, and FDA NDI notifications. Within AIBMR her emphasis has strongly been on hemp extracts, probiotics, and microbial extracts/foods.Read More
Dr. Modica earned her doctorate in Naturopathic Medicine in 2012 from Bastyr University in Seattle, Washington. She continues clinical practice with a focus on chronic illnesses such as diabetes and cardiovascular disease. She earned a high honors Bachelor of Science degree in Cellular and Molecular Biology from the University of Michigan in Ann Arbor. The honors distinction was based on her published work in a basic science developmental neurobiology lab. After her research work and before attending Bastyr, she worked in high-tech and medical device companies as a consultant and business analyst.
Kara Crisp, ND
Scientific and Regulatory Consultant
Kara Crisp, ND, is a Scientific and Regulatory Consultant at AIBMR. Dr. Crisp earned her doctoral degree in naturopathic medicine from the National University of Natural Medicine in Portland, Oregon in 2015. Following graduation, Dr. Crisp cared for patients in private clinical practice with a focus on gastrointestinal dysfunction, Lyme disease and co-infections, and mycotoxin illness for several years in the Portland area. Dr. Crisp currently maintains her naturopathic medical license in the state of Oregon.Read More
Dr. Crisp earned a Bachelor of Science in Microbiology from Colorado State University. Prior to attending NUNM, she worked as a microbiologist in the pharmaceutical industry for 6 years and obtained a certification as a Nationally Registered Certified Microbiologist through 2012. She has an extensive background in validation and maintaining cGMP compliance and defended her self-authored qualification and validation documents to various inspection agencies, including the FDA.
Bean Choi, ND
Scientific and Regulatory Consultant
Bean Choi, ND, is a Scientific and Regulatory Consultant at AIBMR. Dr. Choi earned her doctorate in Naturopathic Medicine and Masters in Acupuncture and Oriental Medicine from Bastyr University in 2013. Prior to her work at AIBMR, Dr. Choi focused primarily on non-pharmaceutical pain management in her practice. She currently maintains her licenses in the state of Washington.Read More
Dr. Choi graduated from the University of Washington with a Bachelor of Science degree in Physiology. She has had a strong interest in pharmacognosy and plant constituents throughout her career and has various additional experiences in the production and manufacturing of herbal supplements.
In 1995, Laura became Operations Director of AIBMR’S Life Sciences Division and after three years was promoted to Chief Financial Officer and Chief Operations Officer. In these roles, Laura provides overall leadership for AIBMR’s finance department and is a key member of the company’s leadership team.Read More
Laura’s 30 years of experience in the natural products industry began with her sales position at the Natural Products Store, now known as Marlene’s Market & Deli, a two-time national winner of “Store of the Year” in its respective category.
Laura’s success in natural products sales attracted the attention of major national dietary supplement manufacturers. She was offered a sales position by KAL, at that time a leading U.S. dietary supplement manufacturer, and relocated to Boston. Laura so quickly and successfully built KAL’s New England territory that she was soon offered a promotion to Product Training Manager for the Naturally, Inc.
Over many years of attending natural product trade shows, Laura always made a point of attending presentations given by AIBMR Life Sciences staff. Inspired by AIBMR Life Sciences research, she applied to work for AIBMR Life Sciences and was hired in 1984 by its publications division, which included Biosocial Publications and the award-winning Life Sciences Press and eventually became the Director of Publishing. During her tenure, she was responsible for the timely publication of a quarterly, peer-reviewed scientific journal as well as many other research publications. Additionally, Laura managed Tacoma Printing Company, AIBMR’s printing division, and established accounts with major book distributors throughout North America.
From 1991 to 1995, Laura was the Operations Director for two national non-profit organizations, Citizens For Health (CFH) and the American Preventive Medical Association (APMA). Her responsibilities included office and human resources management, as well as editorial management of the organizations’ membership newsletters. In 1994, CFH achieved national recognition by winning the “Award of Excellence in Government Relations”, a Federal lobbying award given by the 25,000-member American Society of Association Executives in recognition of its role in successfully organizing national grass roots support for the hotly-contested Dietary Supplement Health and Education Act of 1994, which eventually passed and become law. Laura also worked with APMA to introduce the Access to Medical Freedom Act in Congress, and her leadership was recognized and awarded by the natural products industry.
In 1995, Laura became Operations Director of AIBMR’S Life Sciences Division and after three years was promoted to Chief Financial Officer and Chief Operations Officer. In these roles, Laura provides overall leadership for AIBMR’s finance department and is a key member of the company’s leadership team.
Jared D. Brodin
Director of Information Services
As AIBMR’s Director of Information Services, Jared’s detail includes involvement in corporate marketing and branding strategies, directorship of the firm’s extensive library holdings and acquisitions, coordination of major research projects, and oversight of social media and website functions.